High efficacy of erlotinib in Taiwanese NSCLC patients in an expanded access program study previously treated with chemotherapy
To access this article, please choose from the options below
PII: S0169-5002(08)00109-8
doi:10.1016/j.lungcan.2008.02.023
© 2008 Elsevier Ireland Ltd. All rights reserved.
